fda retatrutide vs. Tirzepatide: What's The Difference? – Forbes Health The FDA has issued warning

Tirzepatide spans 2.5 mg to 15 mg (a 6x range)

Tschop recounted his research with DiMarchi and that of others while he accepted the 2023 Banting Medal for Scientific Achievement at the 2023 American Diabetes Association Scientific Sessions.5 The FDA approved the first GLP-1 agonist, twice-a-day Byetta (exenatide), in 2005.1 Since then, several newer and more powerful medications in the GLP-1 agonist class, such as liraglutide and semaglutide, have received FDA approval for type 2 diabetes, with a higher dose of semaglutide FDA approved for weight loss.2 In mid-2022, the first dual agonist, tirzepetide (a combination of a GLP-1 agonist and a GIP), was FDA approved for type 2 diabetes

doi: 10.1080/10408398.2022.2061909

The SURPASS-CVOT trial for Mounjaro cardiovascular outcomes is ongoing, with data expected by 2029

of Canada, Obesity Statistics in Canada: Report. Accessed: Nov

Seek urgent medical advice for severe persistent abdominal pain, vomiting preventing fluid intake for 24 hours, or signs of pancreatitis or gallbladder disease